| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts for the following articles, which are currently “in press” in biological psychiatry, are available on our website now…
|
|
|
2001
|
49 |
3 |
p. 307-
1 p.
|
artikel
|
| 2 |
Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer’s disease
|
Maelicke, Alfred
|
|
2001
|
49 |
3 |
p. 279-288
10 p.
|
artikel
|
| 3 |
Cognitive effects of nicotine
|
Rezvani, Amir H
|
|
2001
|
49 |
3 |
p. 258-267
10 p.
|
artikel
|
| 4 |
Effects of nicotine on APP secretion and Aβ- or CT105-induced toxicity
|
Seo, Ji-Heui
|
|
2001
|
49 |
3 |
p. 240-247
8 p.
|
artikel
|
| 5 |
Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects
|
George, Tony P
|
|
2001
|
49 |
3 |
p. 300-306
7 p.
|
artikel
|
| 6 |
Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer’s disease
|
Coyle, Joseph
|
|
2001
|
49 |
3 |
p. 289-299
11 p.
|
artikel
|
| 7 |
Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer’s dementia
|
Volkow, Nora D
|
|
2001
|
49 |
3 |
p. 211-220
10 p.
|
artikel
|
| 8 |
Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer’s disease
|
Rattray, Marcus
|
|
2001
|
49 |
3 |
p. 185-193
9 p.
|
artikel
|
| 9 |
Nicotine and amyloid formation
|
Zeng, Hong
|
|
2001
|
49 |
3 |
p. 248-257
10 p.
|
artikel
|
| 10 |
Nicotine and its interaction with β-amyloid protein: a short review
|
Zamani, M.Reza
|
|
2001
|
49 |
3 |
p. 221-232
12 p.
|
artikel
|
| 11 |
Nicotinic mechanisms: potential for therapeutic exploitation
|
Davis, Kenneth L
|
|
2001
|
49 |
3 |
p. 165-
1 p.
|
artikel
|
| 12 |
Nicotinic receptor abnormalities in Alzheimer’s disease
|
Court, Jennifer
|
|
2001
|
49 |
3 |
p. 175-184
10 p.
|
artikel
|
| 13 |
Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications
|
Nordberg, Agneta
|
|
2001
|
49 |
3 |
p. 200-210
11 p.
|
artikel
|
| 14 |
Nicotinic receptor–mediated protection against β-amyloid neurotoxicity
|
Shimohama, Shun
|
|
2001
|
49 |
3 |
p. 233-239
7 p.
|
artikel
|
| 15 |
Nicotinic treatment of Alzheimer’s disease
|
Newhouse, Paul A
|
|
2001
|
49 |
3 |
p. 268-278
11 p.
|
artikel
|
| 16 |
Overview of nicotinic receptors and their roles in the central nervous system
|
Dani, John A
|
|
2001
|
49 |
3 |
p. 166-174
9 p.
|
artikel
|
| 17 |
The association between smoking and Alzheimer’s disease: effects of study design and bias
|
Kukull, Walter A
|
|
2001
|
49 |
3 |
p. 194-199
6 p.
|
artikel
|
Tijdschrift beschrijving